Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 622

1.

Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma.

Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, Malkin D, Ellison DW, VandenBerg SR, Eberhart CG, Sears RC, Roussel MF, Gilbertson RJ, Wechsler-Reya RJ.

Cancer Res. 2019 Mar 18. pii: canres.2565.2018. doi: 10.1158/0008-5472.CAN-18-2565. [Epub ahead of print]

PMID:
30885981
2.

Intratumoral genetic and functional heterogeneity in pediatric glioblastoma.

Hoffman M, Gillmor A, Kunz DJ, Johnston MJ, Nikolic A, Narta K, Zarrei M, King JC, Ellestad K, Dang NH, Cavalli FMG, Kushida M, Coutinho FJ, Zhu Y, Luu B, Ma Y, Mungall AJ, Moore RA, Marra MA, Taylor MD, Pugh TJ, Dirks PB, Strother D, Lafay-Cousin L, Resnick AC, Scherer SW, Senger DL, Simons BD, Chan JA, Morrissy AS, Gallo M.

Cancer Res. 2019 Mar 15. pii: canres.3441.2018. doi: 10.1158/0008-5472.CAN-18-3441. [Epub ahead of print]

PMID:
30877103
3.

An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.

Carrigan G, Whipple S, Taylor MD, Torres AZ, Gossai A, Arnieri B, Tucker M, Hofmeister PP, Lambert P, Griffith SD, Capra WB.

Pharmacoepidemiol Drug Saf. 2019 Mar 14. doi: 10.1002/pds.4758. [Epub ahead of print]

PMID:
30873729
4.

Abnormal submaximal cardiopulmonary exercise parameters predict impaired peak exercise performance in sickle cell anemia patients.

Powell AW, Alsaied T, Niss O, Fleck RJ, Malik P, Quinn CT, Mays WA, Taylor MD, Chin C.

Pediatr Blood Cancer. 2019 Mar 7:e27703. doi: 10.1002/pbc.27703. [Epub ahead of print]

PMID:
30848046
5.

Retraction Note: A homing system targets therapeutic T cells to brain cancer.

Samaha H, Pignata A, Fousek K, Ren J, Lam FW, Stossi F, Dubrulle J, Salsman VS, Krishnan S, Hong SH, Baker ML, Shree A, Gad AZ, Shum T, Fukumura D, Byrd TT, Mukherjee M, Marrelli SP, Orange JS, Joseph SK, Sorensen PH, Taylor MD, Hegde M, Mamonkin M, Jain RK, El-Naggar S, Ahmed N.

Nature. 2019 Mar;567(7746):132. doi: 10.1038/s41586-019-0967-z.

PMID:
30787441
6.

Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.

Fults DW, Taylor MD, Garzia L.

J Neurosurg Pediatr. 2019 Feb 15:1-9. doi: 10.3171/2018.11.PEDS18506. [Epub ahead of print] Review.

PMID:
30771762
7.

Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost.

Zapotocky M, Beera K, Adamski J, Laperierre N, Guger S, Janzen L, Lassaletta A, Figueiredo Nobre L, Bartels U, Tabori U, Hawkins C, Urbach S, Tsang DS, Dirks PB, Taylor MD, Bouffet E, Mabbott DJ, Ramaswamy V.

Cancer. 2019 Feb 15. doi: 10.1002/cncr.31995. [Epub ahead of print]

PMID:
30768777
8.

Medulloblastoma.

Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM.

Nat Rev Dis Primers. 2019 Feb 14;5(1):11. doi: 10.1038/s41572-019-0063-6. Review.

PMID:
30765705
9.

Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation.

Rotz SJ, Powell A, Myers KC, Taylor MD, Jefferies JL, Lane A, El-Bietar JA, Davies SM, Dandoy CE, Ryan TD.

Cardiol Young. 2019 Feb 12:1-6. doi: 10.1017/S104795111800238X. [Epub ahead of print]

PMID:
30744727
10.

Challenges to curing primary brain tumours.

Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson JH, Taylor MD, Workman P, Gilbertson RJ.

Nat Rev Clin Oncol. 2019 Feb 7. doi: 10.1038/s41571-019-0177-5. [Epub ahead of print] Review.

PMID:
30733593
11.

Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death.

Kallay L, Keskin H, Ross A, Rupji M, Moody OA, Wang X, Li G, Ahmed T, Rashid F, Stephen MR, Cottrill KA, Nuckols TA, Xu M, Martinson DE, Tranghese F, Pei Y, Cook JM, Kowalski J, Taylor MD, Jenkins A, Pomeranz Krummel DA, Sengupta S.

J Neurooncol. 2019 Feb 6. doi: 10.1007/s11060-019-03115-0. [Epub ahead of print]

PMID:
30725256
12.

Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.

Beckmann PJ, Larson JD, Larsson AT, Ostergaard JP, Wagner S, Rahrmann EP, Shamsan GA, Otto GM, Williams RL, Wang J, Lee C, Tschida BR, Das P, Dubuc AM, Moriarity BS, Picard D, Wu X, Rodriguez FJ, Rosemarie Q, Krebs RD, Molan AM, Demer AM, Frees MM, Rizzardi AE, Schmechel SC, Eberhart CG, Jenkins RB, Wechsler-Reya RJ, Odde DJ, Huang A, Taylor MD, Sarver AL, Largaespada DA.

Cancer Res. 2019 Mar 1;79(5):905-917. doi: 10.1158/0008-5472.CAN-18-1261. Epub 2019 Jan 23.

PMID:
30674530
13.

Lytic Therapy for Retained Traumatic Hemothorax: A Systematic Review and Meta-analysis.

Hendriksen BS, Kuroki MT, Armen SB, Reed MF, Taylor MD, Hollenbeak CS.

Chest. 2019 Jan 18. pii: S0012-3692(19)30021-2. doi: 10.1016/j.chest.2019.01.007. [Epub ahead of print]

PMID:
30664856
14.

Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.

Robson JP, Remke M, Kool M, Julian E, Korshunov A, Pfister SM, Osborne GW, Taylor MD, Wainwright B, Reynolds BA.

PLoS One. 2019 Jan 18;14(1):e0210665. doi: 10.1371/journal.pone.0210665. eCollection 2019.

15.

PPAR and GST polymorphisms may predict changes in intellectual functioning in medulloblastoma survivors.

Oyefiade A, Erdman L, Goldenberg A, Malkin D, Bouffet E, Taylor MD, Ramaswamy V, Scantlebury N, Law N, Mabbott DJ.

J Neurooncol. 2019 Mar;142(1):39-48. doi: 10.1007/s11060-018-03083-x. Epub 2019 Jan 3.

PMID:
30607709
16.

A functional genomics approach to identify pathways of drug resistance in medulloblastoma.

Bertrand KC, Faria CC, Skowron P, Luck A, Garzia L, Wu X, Agnihotri S, Smith CA, Taylor MD, Mack SC, Rutka JT.

Acta Neuropathol Commun. 2018 Dec 27;6(1):146. doi: 10.1186/s40478-018-0652-8. No abstract available.

17.

Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.

Yin WC, Satkunendran T, Mo R, Morrissy S, Zhang X, Huang ES, Uusküla-Reimand L, Hou H, Son JE, Liu W, Liu YC, Zhang J, Parker J, Wang X, Farooq H, Selvadurai H, Chen X, Sau-Wai Ngan E, Cheng SY, Dirks PB, Angers S, Wilson MD, Taylor MD, Hui CC.

Dev Cell. 2019 Jan 28;48(2):167-183.e5. doi: 10.1016/j.devcel.2018.11.015. Epub 2018 Dec 13.

PMID:
30554998
18.

MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.

Iv M, Zhou M, Shpanskaya K, Perreault S, Wang Z, Tranvinh E, Lanzman B, Vajapeyam S, Vitanza NA, Fisher PG, Cho YJ, Laughlin S, Ramaswamy V, Taylor MD, Cheshier SH, Grant GA, Young Poussaint T, Gevaert O, Yeom KW.

AJNR Am J Neuroradiol. 2019 Jan;40(1):154-161. doi: 10.3174/ajnr.A5899. Epub 2018 Dec 6.

PMID:
30523141
19.

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.

Fukuoka K, Kanemura Y, Shofuda T, Fukushima S, Yamashita S, Narushima D, Kato M, Honda-Kitahara M, Ichikawa H, Kohno T, Sasaki A, Hirato J, Hirose T, Komori T, Satomi K, Yoshida A, Yamasaki K, Nakano Y, Takada A, Nakamura T, Takami H, Matsushita Y, Suzuki T, Nakamura H, Makino K, Sonoda Y, Saito R, Tominaga T, Matsusaka Y, Kobayashi K, Nagane M, Furuta T, Nakada M, Narita Y, Hirose Y, Ohba S, Wada A, Shimizu K, Kurozumi K, Date I, Fukai J, Miyairi Y, Kagawa N, Kawamura A, Yoshida M, Nishida N, Wataya T, Yamaoka M, Tsuyuguchi N, Uda T, Takahashi M, Nakano Y, Akai T, Izumoto S, Nonaka M, Yoshifuji K, Kodama Y, Mano M, Ozawa T, Ramaswamy V, Taylor MD, Ushijima T, Shibui S, Yamasaki M, Arai H, Sakamoto H, Nishikawa R, Ichimura K; Japan Pediatric Molecular Neuro-Oncology Group (JPMNG).

Acta Neuropathol Commun. 2018 Dec 4;6(1):134. doi: 10.1186/s40478-018-0630-1.

20.

The influence of depth and a subsea pipeline on fish assemblages and commercially fished species.

Bond T, Partridge JC, Taylor MD, Cooper TF, McLean DL.

PLoS One. 2018 Nov 26;13(11):e0207703. doi: 10.1371/journal.pone.0207703. eCollection 2018.

21.

Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial.

Sandberg DI, Yu B, Patel R, Hagan J, Miesner E, Sabin J, Smith S, Fletcher S, Shah MN, Sirianni RW, Taylor MD.

J Neurooncol. 2019 Jan;141(2):449-457. doi: 10.1007/s11060-018-03055-1. Epub 2018 Nov 20.

PMID:
30460634
22.

Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.

Tsang DS, Murray L, Ramaswamy V, Zapotocky M, Tabori U, Bartels U, Huang A, Dirks PB, Taylor MD, Hawkins C, Bouffet E, Laperriere N.

Neuro Oncol. 2019 Mar 18;21(4):547-557. doi: 10.1093/neuonc/noy191.

PMID:
30452715
23.

Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.

Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, Li G, Wechsler-Reya RJ, Reimand J, Cho YJ, Taylor MD, Weissman IL, Mitra SS, Cheshier SH.

Nat Commun. 2018 Nov 2;9(1):4651. doi: 10.1038/s41467-018-07182-1.

24.

Survey design for quantifying perfluoroalkyl acid concentrations in fish, prawns and crabs to assess human health risks.

Taylor MD.

Sci Total Environ. 2019 Feb 20;652:59-65. doi: 10.1016/j.scitotenv.2018.10.117. Epub 2018 Oct 10.

PMID:
30359802
25.

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U.

J Clin Invest. 2019 Jan 2;129(1):223-229. doi: 10.1172/JCI121303. Epub 2018 Dec 3.

26.

How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma.

Khakban A, Mohammadi T, Lynd LD, Mabbott DJ, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor MD, Marra CA.

Patient Prefer Adherence. 2018 Oct 10;12:2103-2110. doi: 10.2147/PPA.S168739. eCollection 2018.

27.

BMI1 is a therapeutic target in recurrent medulloblastoma.

Bakhshinyan D, Venugopal C, Adile AA, Garg N, Manoranjan B, Hallett R, Wang X, Mahendram S, Vora P, Vijayakumar T, Subapanditha M, Singh M, Kameda-Smith MM, Qazi M, McFarlane N, Mann A, Ajani OA, Yarascavitch B, Ramaswamy V, Farooq H, Morrissy S, Cao L, Sydorenko N, Baiazitov R, Du W, Sheedy J, Weetall M, Moon YC, Lee CS, Kwiecien JM, Delaney KH, Doble B, Cho YJ, Mitra S, Kaplan D, Taylor MD, Davis TW, Singh SK.

Oncogene. 2019 Mar;38(10):1702-1716. doi: 10.1038/s41388-018-0549-9. Epub 2018 Oct 22.

PMID:
30348991
28.

Magnetic resonance imaging computation of intracardiac flow derangements in heart failure dyssynchrony.

Taylor MD, Kutty S.

Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H10-H12. doi: 10.1152/ajpheart.00676.2018. Epub 2018 Oct 19. No abstract available.

PMID:
30339497
29.

A database of marine larval fish assemblages in Australian temperate and subtropical waters.

Smith JA, Miskiewicz AG, Beckley LE, Everett JD, Garcia V, Gray CA, Holliday D, Jordan AR, Keane J, Lara-Lopez A, Leis JM, Matis PA, Muhling BA, Neira FJ, Richardson AJ, Smith KA, Swadling KM, Syahailatua A, Taylor MD, van Ruth PD, Ward TM, Suthers IM.

Sci Data. 2018 Oct 16;5:180207. doi: 10.1038/sdata.2018.207.

30.

Bioinformatic Strategies for the Genomic and Epigenomic Characterization of Brain Tumors.

Ramaswamy V, Taylor MD.

Methods Mol Biol. 2019;1869:37-56. doi: 10.1007/978-1-4939-8805-1_4.

PMID:
30324512
31.

Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.

Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, Li G, Wechsler-Reya RJ, Reimand J, Cho YJ, Taylor MD, Weissman IL, Mitra SS, Cheshier SH.

Nat Commun. 2018 Oct 8;9(1):4121. doi: 10.1038/s41467-018-06564-9. Erratum in: Nat Commun. 2018 Nov 2;9(1):4651.

32.

Evaluation of pulmonary artery stenosis in congenital heart disease patients using functional diagnostic parameters: An in vitro study.

D'Souza GA, Banerjee RK, Taylor MD.

J Biomech. 2018 Nov 16;81:58-67. doi: 10.1016/j.jbiomech.2018.09.014. Epub 2018 Sep 15.

PMID:
30293825
33.

Physiologically-based pharmacokinetic modeling suggests similar bioavailability of Mn from diet and drinking water.

Song G, Van Landingham CB, Gentry PR, Taylor MD, Keene AM, Andersen ME, Clewell HJ, Yoon M.

Toxicol Appl Pharmacol. 2018 Nov 15;359:70-81. doi: 10.1016/j.taap.2018.09.023. Epub 2018 Sep 20.

34.

p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.

Wei Y, Maximov V, Morrissy SA, Taylor MD, Pallas DC, Kenney AM.

Mol Cancer Res. 2019 Jan;17(1):186-198. doi: 10.1158/1541-7786.MCR-18-0485. Epub 2018 Sep 17.

PMID:
30224541
35.

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.

Purzner T, Purzner J, Buckstaff T, Cozza G, Gholamin S, Rusert JM, Hartl TA, Sanders J, Conley N, Ge X, Langan M, Ramaswamy V, Ellis L, Litzenburger U, Bolin S, Theruvath J, Nitta R, Qi L, Li XN, Li G, Taylor MD, Wechsler-Reya RJ, Pinna LA, Cho YJ, Fuller MT, Elias JE, Scott MP.

Sci Signal. 2018 Sep 11;11(547). pii: eaau5147. doi: 10.1126/scisignal.aau5147.

PMID:
30206138
36.

Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.

Forget A, Martignetti L, Puget S, Calzone L, Brabetz S, Picard D, Montagud A, Liva S, Sta A, Dingli F, Arras G, Rivera J, Loew D, Besnard A, Lacombe J, Pagès M, Varlet P, Dufour C, Yu H, Mercier AL, Indersie E, Chivet A, Leboucher S, Sieber L, Beccaria K, Gombert M, Meyer FD, Qin N, Bartl J, Chavez L, Okonechnikov K, Sharma T, Thatikonda V, Bourdeaut F, Pouponnot C, Ramaswamy V, Korshunov A, Borkhardt A, Reifenberger G, Poullet P, Taylor MD, Kool M, Pfister SM, Kawauchi D, Barillot E, Remke M, Ayrault O.

Cancer Cell. 2018 Sep 10;34(3):379-395.e7. doi: 10.1016/j.ccell.2018.08.002.

PMID:
30205043
37.

A homing system targets therapeutic T cells to brain cancer.

Samaha H, Pignata A, Fousek K, Ren J, Lam FW, Stossi F, Dubrulle J, Salsman VS, Krishnan S, Hong SH, Baker ML, Shree A, Gad AZ, Shum T, Fukumura D, Byrd TT, Mukherjee M, Marrelli SP, Orange JS, Joseph SK, Sorensen PH, Taylor MD, Hegde M, Mamonkin M, Jain RK, El-Naggar S, Ahmed N.

Nature. 2018 Sep;561(7723):331-337. doi: 10.1038/s41586-018-0499-y. Epub 2018 Sep 5. Retraction in: Nature. 2019 Mar;567(7746):132.

38.

Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.

Leal LF, Evangelista AF, de Paula FE, Caravina Almeida G, Carloni AC, Saggioro F, Stavale JN, Malheiros SMF, Mançano B, de Oliveira MA, Luu B, Neder L, Taylor MD, Reis RM.

Neuropathology. 2018 Oct;38(5):475-483. doi: 10.1111/neup.12508. Epub 2018 Aug 28.

PMID:
30155928
39.

Fish associated with a subsea pipeline and adjacent seafloor of the North West Shelf of Western Australia.

Bond T, Partridge JC, Taylor MD, Langlois TJ, Malseed BE, Smith LD, McLean DL.

Mar Environ Res. 2018 Oct;141:53-65. doi: 10.1016/j.marenvres.2018.08.003. Epub 2018 Aug 4.

PMID:
30107887
40.

Three-dimensional printing and virtual surgery for congenital heart procedural planning.

Moore RA, Riggs KW, Kourtidou S, Schneider K, Szugye N, Troja W, D'Souza G, Rattan M, Bryant R 3rd, Taylor MD, Morales DLS.

Birth Defects Res. 2018 Aug 1;110(13):1082-1090. doi: 10.1002/bdr2.1370. Epub 2018 Aug 6. Review.

PMID:
30079634
41.

Heterogeneity within the PF-EPN-B ependymoma subgroup.

Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, McLendon RE, Lipp ES, Gururangan S, Grossbach A, French P, Kros JM, van Veelen MC, Rao AAN, Giannini C, Leary S, Jung S, Faria CC, Mora J, Schüller U, Alonso MM, Chan JA, Klekner A, Chambless LB, Hwang EI, Massimino M, Eberhart CG, Karajannis MA, Lu B, Liau LM, Zollo M, Ferrucci V, Carlotti C, Tirapelli DPC, Tabori U, Bouffet E, Ryzhova M, Ellison DW, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Pfister SM, Taylor MD, Aldape K, Pajtler KW, Kool M, Ramaswamy V.

Acta Neuropathol. 2018 Aug;136(2):227-237. doi: 10.1007/s00401-018-1888-x. Epub 2018 Jul 17.

PMID:
30019219
42.

Cardiac MRI assessment in children and young adults with end-stage renal disease
.

Avendt MB, Taylor MD, Mitsnefes MM.

Clin Nephrol. 2018 Sep;90(3):172-179. doi: 10.5414/CN109271.

PMID:
29974855
43.

Use of the Litomosoides sigmodontis Infection Model of Filariasis to Study Type 2 Immunity.

Fulton A, Babayan SA, Taylor MD.

Methods Mol Biol. 2018;1799:11-26. doi: 10.1007/978-1-4939-7896-0_2.

PMID:
29956140
44.

TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma.

Santhana Kumar K, Neve A, Guerreiro Stucklin AS, Kuzan-Fischer CM, Rushing EJ, Taylor MD, Tripolitsioti D, Behrmann L, Kirschenbaum D, Grotzer MA, Baumgartner M.

Cell Rep. 2018 Jun 26;23(13):3798-3812.e8. doi: 10.1016/j.celrep.2018.05.083.

45.

CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma.

Liang L, Coudière-Morrison L, Tatari N, Stromecki M, Fresnoza A, Porter CJ, Del Bigio MR, Hawkins C, Chan JA, Ryken TC, Taylor MD, Ramaswamy V, Werbowetski-Ogilvie TE.

Cancer Res. 2018 Aug 15;78(16):4745-4759. doi: 10.1158/0008-5472.CAN-18-0027. Epub 2018 Jun 21.

PMID:
29930101
46.

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.

Pajtler KW, Wen J, Sill M, Lin T, Orisme W, Tang B, Hübner JM, Ramaswamy V, Jia S, Dalton JD, Haupfear K, Rogers HA, Punchihewa C, Lee R, Easton J, Wu G, Ritzmann TA, Chapman R, Chavez L, Boop FA, Klimo P, Sabin ND, Ogg R, Mack SC, Freibaum BD, Kim HJ, Witt H, Jones DTW, Vo B, Gajjar A, Pounds S, Onar-Thomas A, Roussel MF, Zhang J, Taylor JP, Merchant TE, Grundy R, Tatevossian RG, Taylor MD, Pfister SM, Korshunov A, Kool M, Ellison DW.

Acta Neuropathol. 2018 Aug;136(2):211-226. doi: 10.1007/s00401-018-1877-0. Epub 2018 Jun 16.

PMID:
29909548
47.

Bioaccumulation of perfluoroalkyl substances in exploited fish and crustaceans: Spatial trends across two estuarine systems.

Taylor MD, Beyer-Robson J, Johnson DD, Knott NA, Bowles KC.

Mar Pollut Bull. 2018 Jun;131(Pt A):303-313. doi: 10.1016/j.marpolbul.2018.04.029. Epub 2018 May 7.

PMID:
29886951
48.

Abiotic drivers of activity in a large, free-ranging, freshwater teleost, Murray cod (Maccullochella peelii).

Thiem JD, Wooden IJ, Baumgartner LJ, Butler GL, Forbes J, Taylor MD, Watts RJ.

PLoS One. 2018 Jun 8;13(6):e0198972. doi: 10.1371/journal.pone.0198972. eCollection 2018.

49.

Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.

Rivero-Hinojosa S, Lau LS, Stampar M, Staal J, Zhang H, Gordish-Dressman H, Northcott PA, Pfister SM, Taylor MD, Brown KJ, Rood BR.

Acta Neuropathol Commun. 2018 Jun 7;6(1):48. doi: 10.1186/s40478-018-0548-7.

50.

Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma.

Thompson EM, Brown M, Dobrikova E, Ramaswamy V, Taylor MD, McLendon R, Sanks J, Chandramohan V, Bigner D, Gromeier M.

J Neuropathol Exp Neurol. 2018 Aug 1;77(8):696-702. doi: 10.1093/jnen/nly045.

PMID:
29878245

Supplemental Content

Loading ...
Support Center